A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate if necitumumab added to standard chemotherapy
of paclitaxel and carboplatin is more effective to treat cancer than the standard
chemotherapy of paclitaxel and carboplatin alone.